home / stock / hjli / hjli news

HJLI News and Press, Hancock Jaffe Laboratories Inc. From 12/21/20

Stock Information
Company Name: Hancock Jaffe Laboratories Inc.
Stock Symbol: HJLI
Market: NASDAQ
Menu
HJLI HJLI Quote HJLI Short HJLI News HJLI Articles HJLI Message Board
Get HJLI Alerts

News, Short Squeeze, Breakout and More Instantly...
HJLI - Hancock Jaffe Deemed Compliant With All NASDAQ Continued Listing Requirements

Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA / ACCESSWIRE / December 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal n...
HJLI - MARA, NXTD, ZYNE and SCYX among midday movers

Gainers: MingZhu Logistics (YGMZ) +237%.Nxt-ID (NXTD) +99%.PainReform (PRFX) +39%.Takung Art (TKAT) +39%.Avenue Therapeutics (ATXI) +31%.Eloxx Pharmaceuticals (ELOX) +30%.Jupiter Wellness (JUPW) +29%.Vivos Therapeutics (VVOS) +25%.Cogent Biosciences (COGT) +24%.Marathon Patent ...

HJLI - Vivos Therapeutics, Jupiter Wellness leads healthcare gainers; BioCardia, SCYNEXIS among major losers

Gainers: Vivos Therapeutics (VVOS) +51%, Jupiter Wellness (JUPW) +21%, Evolus (EOLS) +27%, PainReform (PRFX) +24%, Rite Aid (RAD) +23%.Losers: BioCardia (BCDA) -23%, SCYNEXIS (SCYX) -19%, Zynerba Pharmaceuticals (ZYNE) -15%, Han...

HJLI - Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone

Electrocardiograms Indicate Good Cardiac Function for Both Patients IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergo...
HJLI - APHA, TLRY among premarket gainers

Sio Gene Therapies (SIOX) +42% on positive AXO-AAV-GM1 data in nerve cell disorder.Good Times Restaurants (GTIM) +27% on Q4 results.Tilray (TLRY) +27% as company to combine with Aphria to create largest global cannabis company.DAVIDsTEA (DTEA) +25% on Q3 results.NeuBa...

HJLI - Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data

Patients Show Significant Improvements in Reflux, VCSS, and VAS Scores IRVINE, CA / ACCESSWIRE / December 15, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final ag...

HJLI - Anchiano Therapeutics, Prevail Therapeutics leads healthcare gainers; Mirum Pharmaceuticals, Mesoblast among major losers

Gainers: Anchiano Therapeutics ANCN +173%, Prevail Therapeutics PRVL +84%, BioCardia (BCDA) +40%, Solid Biosciences (SLDB) +37%, OncoCyte OCX +32%.Losers: Mirum Pharmaceuticals (MIRM) -21%, Mesoblast (MESO) -18%, Rubius Therapeutics ...
HJLI - Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient

Final Patient in First-in-Human Study Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 14 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today tha...

HJLI - XXII, VTVT, SLS and NBRV among midday movers

Gainers: Sonoma Pharmaceuticals (SNOA) +87%.aTyr Pharma (LIFE) +65%.NantHealth (NH) +63%.vTv Therapeutics (VTVT) +55%.Equus Total Return (EQS) +45%Hancock Jaffe Laboratories (HJLI) +34%.MDJM (MDJH) +25%.Foresight Autonomous (FRSX) +23%.Solid Biosciences (SLDB) +22%.22...

HJLI - Hancock Jaffe to Provide VenoValve and CoreoGraft Updates at Ladenburg Thalmann R&D Showcase Webinar on December 16, 2020

VenoValve and CoreoGraft Primary Investigators to Present at Webinar IRVINE, CA / ACCESSWIRE / December 10 , 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that on Wednesday, December 1...
Previous 10 Next 10